389 related articles for article (PubMed ID: 29554974)
1. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment.
Pardo-Marín L; Martínez-Subiela S; Pastor J; Tvarijonaviciute A; Garcia-Martinez JD; Segarra S; Cerón JJ
BMC Vet Res; 2017 Jan; 13(1):31. PubMed ID: 28114941
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
[TBL] [Abstract][Full Text] [Related]
4. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
[TBL] [Abstract][Full Text] [Related]
5. Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease.
Cavalera MA; Gernone F; Uva A; D'Ippolito P; Roura X; Paltrinieri S; Zatelli A
Parasit Vectors; 2021 Oct; 14(1):525. PubMed ID: 34629081
[TBL] [Abstract][Full Text] [Related]
6. Short term impacts of meglumine antimoniate treatment on kidney function in dogs with clinical leishmaniosis.
Daza González MA; Miró G; Fermín Rodríguez M; Rupérez Noguer C; Fragío Arnold C
Res Vet Sci; 2019 Oct; 126():131-138. PubMed ID: 31491669
[TBL] [Abstract][Full Text] [Related]
7. Effects of allopurinol treatment on the progression of chronic nephritis in Canine leishmaniosis (Leishmania infantum).
Plevraki K; Koutinas AF; Kaldrymidou H; Roumpies N; Papazoglou LG; Saridomichelakis MN; Savvas I; Leondides L
J Vet Intern Med; 2006; 20(2):228-33. PubMed ID: 16594576
[TBL] [Abstract][Full Text] [Related]
8. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
de Jong MK; Rappoldt A; Broere F; Piek CJ
Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nephrotoxicity and ototoxicity of aminosidine (paromomycin)-allopurinol combination in dogs with leishmaniosis due to Leishmania infantum: A randomized, blinded, controlled study.
Kasabalis D; Chatzis MK; Apostolidis K; Xenoulis PG; Buono A; Petanides T; Leontides LS; Polizopoulou ZS; Steiner JM; Suchodolski JS; Saridomichelakis MN
Exp Parasitol; 2019 Nov; 206():107768. PubMed ID: 31539540
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment.
Cantos-Barreda A; Escribano D; Martínez-Subiela S; Pardo-Marín L; Segarra S; Cerón JJ
Vet Immunol Immunopathol; 2018 Apr; 198():65-69. PubMed ID: 29571520
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and management of a case of leishmaniosis in a dog imported to Australia.
Best MP; Ash A; Bergfeld J; Barrett J
Vet Parasitol; 2014 May; 202(3-4):292-5. PubMed ID: 24768315
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major infection in a dog with cutaneous manifestations.
Baneth G; Nachum-Biala Y; Shabat Simon M; Brenner O; Gaier S; Rojas A; Yasur-Landau D
Parasit Vectors; 2016 May; 9(1):246. PubMed ID: 27160919
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis.
Cantos-Barreda A; Escribano D; Cerón JJ; Bernal LJ; Furlanello T; Tecles F; Pardo-Marín L; Martínez-Subiela S
Vet Parasitol; 2018 Aug; 260():63-68. PubMed ID: 30197018
[TBL] [Abstract][Full Text] [Related]
15. Dogs with leishmaniosis: how are we managing proteinuria in daily practice? A Portuguese questionnaire-based study.
Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
Parasit Vectors; 2022 Apr; 15(1):125. PubMed ID: 35410442
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers and renal arterial resistive index in dogs naturally infected with Leishmania infantum.
de Oliveira Frazilio F; de Almeida Borges F; de Souza AI; Palumbo MIP; do Nascimento Ramos CA; Freire DH; Galvão ALB; de Freitas MG; Barbosa FB
Parasitol Res; 2018 Nov; 117(11):3399-3405. PubMed ID: 30069827
[TBL] [Abstract][Full Text] [Related]
17. Variation of proteinuria in dogs with leishmaniasis treated with meglumine antimoniate and allopurinol: a retrospective study.
Pierantozzi M; Roura X; Paltrinieri S; Poggi M; Zatelli A
J Am Anim Hosp Assoc; 2013; 49(4):231-6. PubMed ID: 23690493
[TBL] [Abstract][Full Text] [Related]
18. Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Saridomichelakis MN; Xenoulis PG; Chatzis MK; Kasabalis D; Steiner JM; Suchodolski JS; Petanides T
Vet Parasitol; 2013 Oct; 197(1-2):22-8. PubMed ID: 23685064
[TBL] [Abstract][Full Text] [Related]
19. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S
Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum symmetric dimethylarginine as a biomarker of kidney disease in canine leishmaniosis due to Leishmania infantum.
Giapitzoglou S; Saridomichelakis MN; Leontides LS; Kasabalis D; Chatzis M; Apostolidis K; Theodorou K; Roumpeas E; Mylonakis ME
Vet Parasitol; 2020 Jan; 277():109015. PubMed ID: 31874403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
